查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1933318

臨床試驗人工智慧市場規模、佔有率、成長、全球產業分析：依類型、應用、區域洞察和預測（2026-2034 年）

AI in Clinical Trials Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 190 Pages | 商品交期: 請詢問到貨日

價格

臨床試驗人工智慧市場成長驅動因素

由於藥物研發日益複雜、臨床試驗成本不斷上升以及人工智慧技術在優化試驗流程方面的應用，全球臨床試驗人工智慧市場正經歷快速成長。該市場在 2025 年的估值為 38 億美元，2026 年成長至 55 億美元，預計到 2034 年將達到 1,209.1 億美元，預測期內複合年增長率高達 47.14%。

人工智慧正日益融入臨床試驗設計、實施、監測和數據分析的各個階段。這些人工智慧技術正在幫助製藥公司和合約研究組織 (CRO) 加快研發進程、簡化患者招募、實現資料清洗自動化並支援適應性試驗設計。 例如，IQVIA Inc. 於 2022 年 9 月報告稱，與傳統試驗流程相比，分散式臨床試驗在時間和成本方面均實現了顯著節省。

該市場由 IQVIA Inc.、達梭系統和 AiCure 等公司引領，這些公司強大的區域影響力、廣泛的產品組合和創新的 AI 解決方案為其市場領導地位提供了支撐。

市場動態

市場驅動因素

擴大採用基於 AI 的解決方案來應對臨床試驗的高成本和複雜性是關鍵驅動因素。 AI 可以加快患者招募、即時監測和預測結果建模，從而縮短試驗週期並降低失敗風險。全球臨床試驗數量的不斷增加進一步加速了 AI 的應用。

市場限制因子

資料隱私和監管合規仍然是主要的限制因素。 美國的 HIPAA 和歐洲的 GDPR 等法規限制了跨國資料交換和多中心協作，增加了營運成本和時間。這些因素減緩了人工智慧在國際臨床試驗中的應用。

市場機會

新興市場臨床試驗的擴展蘊藏著巨大的成長潛力。亞太地區、拉丁美洲以及中東和非洲等地區具有成本優勢，且擁有尚未開發的患者群。人工智慧可以優化這些地區分散的醫療保健數據和試驗物流，從而實現更快、更有效率的試驗執行。

市場挑戰

將人工智慧解決方案與傳統 IT 系統整合面臨諸多挑戰。傳統的電子資料採集 (EDC) 系統、紙本記錄和分散的 IT 基礎設施阻礙了人工智慧的無縫實施。即使部署了人工智慧工具，低效的整合也會限制其潛力。

市場趨勢

一個關鍵趨勢是轉向分散式和混合式臨床試驗的轉變。 這些包括遠端患者監測、遠距醫療和分散式研究藥物分發。分散式臨床試驗 (DCT) 模型的採用率從疫情前的 28% 增長到疫情後的 87%，95% 的申辦方計劃進一步採用，這凸顯了人工智慧在支援這些模型方面的強大作用。

細分分析

依產品/服務：

  • 到 2026 年，服務細分市場將佔主導地位，市場佔有率達 52.74%，這主要得益於外包給合約研究組織 (CRO) 和專業服務提供者。
  • 軟體/平台在數據分析、患者監測和試驗管理方面對服務進行了補充。

依技術：

  • 到 2026 年，機器學習 (ML) 將佔 55.90% 的市場佔有率，並在預測分析和試驗優化方面得到廣泛應用。
  • 自然語言處理 (NLP) 預計在預測期內將以 44.74% 的複合年增長率增長。

依應用領域劃分：

  • 病患招募和留存將在 2026 年以 31.45% 的市場佔有率引領市場，有助於優化入組流程並減少試驗延誤。
  • 預測分析和結果建模預計將以 52.05% 的市佔率成長。

依專科領域劃分：

  • 腫瘤學將在 2026 年以 39.25% 的市佔率引領市場，這主要得益於人工智慧在複雜藥物分子和生物標記方面的應用。
  • 神經病學預計在預測期內將以 48.98% 的複合年增長率增長。

依最終使用者劃分：

  • 到 2025 年，製藥公司將以 59.9% 的市場佔有率引領市場，它們將利用龐大的臨床數據集和合作夥伴關係來實施人工智慧。
  • 合約研究組織 (CRO) 預計將以 48.56% 的複合年增長率成長。

區域展望

  • 北美：在 2025 年以 19.8 億美元的市場規模引領市場，預計到 2026 年將成長至 28.7 億美元，這主要得益於美國臨床試驗投資的推動。預計到 2026 年，美國市場規模將達到 26.4 億美元。
  • 歐洲：2025 年市場規模為 7.5 億美元，由於人工智慧在腫瘤學和罕見疾病試驗中的應用，預計將實現強勁增長。 預計到2026年，英國、德國和法國的市場規模將分別達到2.3億美元、2.6億美元和1.4億美元。 亞太地區：預計到2025年，亞太地區市場規模將達到8.3億美元，其中日本、中國和印度的市場規模預計到2026年將分別達到2.7億美元、3.1億美元和2.4億美元。 拉丁美洲：預計2025年，拉丁美洲市場規模將達到1.5億美元，成長較為溫和。 中東和非洲：海灣合作委員會（GCC）的市場規模預計到2025年將達到4000萬美元，隨著其法院基礎設施的現代化，該市場正穩步增長。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 人工智慧在臨床試驗中的技術進步
  • 主要國家的監管環境
  • 在臨床試驗中採用和實施人工智慧解決方案所面臨的挑戰
  • 人工智慧在臨床試驗中的關鍵績效指標
  • 主要產業發展動態－併購、合作等

章節5：全球臨床試驗人工智慧市場分析、洞察與預測（2021-2034）

  • 市場分析、洞察與預測 - 依產品/服務分類
    • 軟體/平台
    • 服務
  • 市場分析、洞察與預測 - 依技術分類
    • 機器學習
    • 自然語言處理
    • 其他
  • 市場分析、洞察與預測 - 依應用分類
    • 病患招募與保留
    • 研究設計與方案優化
    • 資料收集與管理
    • 預測分析與結果模型
    • 其他
  • 市場分析、洞察與預測 - 依專業領域
    • 腫瘤科
    • 神經科
    • 心血管科
    • 其他
  • 市場分析、洞察與預測 - 依最終用戶劃分
    • 製藥公司
    • 合約研究組織 (CRO)
    • 其他
  • 市場分析、洞察與預測 - 依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章：北美臨床試驗人工智慧市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲臨床試驗人工智慧臨床試驗市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 歐洲其他地區

第八章：亞太地區臨床試驗人工智慧市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章：拉丁美洲臨床試驗人工智慧市場分析、洞察與預測2021-2034

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第十章 中東和非洲臨床試驗人工智慧市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會
    • 南非
    • 中東和非洲其他地區

第十一章 競爭分析

  • 全球市佔率分析（2025）
  • 公司簡介
  • IQVIA Inc.
  • Dassault Systemes
  • AiCure
  • Insilico Medicine
  • TEMPUS
  • Median Technologies
  • Saama
  • IBM
  • NVIDIA Corporation
  • Phesi
Product Code: FBI114081

Growth Factors of AI in clinical trials Market

The global AI in clinical trials market is witnessing exponential growth due to the increasing complexity of drug development, rising clinical trial costs, and the adoption of AI technologies to optimize trial processes. The market was valued at USD 3.8 billion in 2025, expected to grow to USD 5.5 billion in 2026, and projected to reach USD 120.91 billion by 2034, reflecting a remarkable CAGR of 47.14% during the forecast period.

Artificial intelligence is being increasingly integrated across clinical trial design, execution, monitoring, and data analysis. These AI technologies help pharmaceutical companies and contract research organizations (CROs) reduce timelines, streamline patient recruitment, automate data cleaning, and enable adaptive trial designs. For example, in September 2022, IQVIA Inc. reported that decentralized clinical trials delivered measurable reductions in both time and cost compared to traditional trial workflows.

The market is dominated by companies such as IQVIA Inc., Dassault Systemes, and AiCure, with strong geographic presence, broad product portfolios, and innovative AI solutions supporting their leadership positions.

Market Dynamics

Market Drivers

Rising adoption of AI-based solutions to tackle high costs and complexity in clinical trials is a primary driver. AI allows faster patient recruitment, real-time monitoring, and predictive outcome modeling, resulting in reduced trial durations and lower failure risks. The increasing volume of clinical trials worldwide further accelerates AI adoption.

Market Restraints

Data privacy and regulatory compliance remain key restraints. Regulations like HIPAA in the U.S. and GDPR in Europe limit cross-border data exchange and multi-site collaborations, increasing operational costs and time. These factors slow adoption of AI in multinational clinical trials.

Market Opportunities

The expansion of clinical trials in emerging markets offers significant growth potential. Regions like Asia Pacific, Latin America, and Middle East & Africa provide cost advantages and untapped patient populations. AI can optimize fragmented healthcare data and trial logistics in these regions, enabling faster and efficient trial execution.

Market Challenges

Integration of AI solutions with traditional IT systems poses challenges. Legacy electronic data capture (EDC) systems, paper-based records, and fragmented IT infrastructure hinder seamless AI deployment. Even when AI tools are implemented, inefficiencies in integration can limit their potential.

Market Trends

A major trend is the shift toward decentralized and hybrid clinical trials, which include remote patient monitoring, telemedicine, and distributed investigational-product logistics. Adoption of decentralized clinical trial (DCT) models rose from 28% pre-pandemic to 87% post-pandemic, with 95% of sponsors planning increased use, showcasing the strong role of AI in supporting these models.

Segmentation Analysis

By Offering:

  • Services segment dominated in 2026 with 52.74% share, driven by outsourcing to CROs and specialized service providers.
  • Software/platforms complement services for data analytics, patient monitoring, and trial management.

By Technology:

  • Machine learning (ML) accounted for 55.90% share in 2026, widely applied for predictive analytics and trial optimization.
  • Natural language processing (NLP) is expected to grow at 44.74% CAGR during the forecast period.

By Application:

  • Patient recruitment & retention led in 2026 with 31.45% share, optimizing enrollment and reducing trial delays.
  • Predictive analytics & outcome modeling is projected to witness 52.05% growth.

By Specialty:

  • Oncology dominated in 2026 with 39.25% share, driven by complex drug molecules and use of AI for biomarkers.
  • Neurology is projected to grow at 48.98% CAGR during the forecast period.

By End-User:

  • Pharmaceutical companies dominated in 2025 with 59.9% share, leveraging large clinical datasets and partnerships for AI deployment.
  • CROs are projected to grow at 48.56% CAGR.

Regional Outlook

  • North America: Dominated with USD 1.98 billion in 2025, growing to USD 2.87 billion in 2026, driven by U.S. clinical trial investments. The U.S. market is expected to reach USD 2.64 billion in 2026.
  • Europe: Valued at USD 0.75 billion in 2025, with strong growth due to AI adoption in oncology and rare disease trials. UK, Germany, and France markets are projected to reach USD 0.23B, 0.26B, 0.14B respectively in 2026.
  • Asia Pacific: Estimated at USD 0.83 billion in 2025, with Japan, China, and India projected at USD 0.27B, 0.31B, 0.24B in 2026.
  • Latin America: USD 0.15 billion in 2025, moderate growth expected.
  • Middle East & Africa: GCC valued at USD 0.04 billion in 2025, growing steadily with modernization of trial infrastructure.

Competitive Landscape

The market is semi-consolidated, led by IQVIA, Dassault Systemes, AiCure, Insilico Medicine, TEMPUS, Median Technologies, Saama, IBM, NVIDIA, and Phesi. These players focus on AI-powered solutions for patient recruitment, protocol optimization, and clinical trial analytics.

Key Developments:

  • Sept 2025: PhaseV & Bioforum partnership for AI/ML-based clinical trials efficiency.
  • June 2025: Advarra introduced Council for Responsible AI in Clinical Trials.
  • April 2025: ConcertAI & Bayer AG multi-year agreement for AI-driven precision oncology trials.
  • March 2025: EMA cleared AIM-NASH AI tool for fatty liver disease severity identification.

Conclusion

The global AI in clinical trials market is projected to grow from USD 3.8 billion in 2025 to USD 120.91 billion by 2034, at a CAGR of 47.14%. Growth is driven by increasing clinical trial complexity, adoption of AI technologies in patient recruitment, predictive analytics, and decentralized trials. Despite challenges in data privacy, regulatory compliance, and legacy system integration, opportunities in emerging markets, oncology, and neurology clinical trials will continue to propel the market globally.

Segmentation By Offering

  • Software / Platforms
  • Services

By Technology

  • Machine Learning
  • Natural Language Processing
  • Others

By Application

  • Patient Recruitment & Retention
  • Trial Design & Protocol Optimization
  • Data Collection & Management
  • Predictive Analytics & Outcome Modeling
  • Others

By Specialty

  • Oncology
  • Neurology
  • Cardiovascular
  • Others

By End User

  • Pharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Others

By Geography

  • North America (By Offering, Technology, Application, Specialty, End User, and Country)
    • U.S.
    • Canada
  • Europe (By Offering, Technology, Application, Specialty, End User, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Offering, Technology, Application, Specialty, End User, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Offering, Technology, Application, Specialty, End User, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Offering, Technology, Application, Specialty, End User, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Technological Advancements Pertaining to the Artificial Intelligence in Clinical Trials
  • 4.2. Regulatory Scenario for Key Countries
  • 4.3. Challenges Faced During Adoption and Implementation of AI-based Solutions in Clinical Trials
  • 4.4. Key Performance Indicators for Artificial Intelligence in the Clinical Trials Market
  • 4.5. Key Industry Developments - Mergers, Acquisitions, Partnerships, etc.

5. Global AI in Clinical Trials Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Offering
    • 5.1.1. Software/Platforms
    • 5.1.2. Services
  • 5.2. Market Analysis, Insights and Forecast - By Technology
    • 5.2.1. Machine Learning
    • 5.2.2. Natural Language Processing
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Patient Recruitment & Retention
    • 5.3.2. Trial Design & Protocol Optimization
    • 5.3.3. Data Collection & Management
    • 5.3.4. Predictive Analytics & Outcome Modelling
    • 5.3.5. Others
  • 5.4. Market Analysis, Insights and Forecast - By Specialty
    • 5.4.1. Oncology
    • 5.4.2. Neurology
    • 5.4.3. Cardiovascular
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By End User
    • 5.5.1. Pharmaceutical Companies
    • 5.5.2. Contract Research Organizations (CROs)
    • 5.5.3. Others
  • 5.6. Market Analysis, Insights and Forecast - By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East & Africa

6. North America AI in Clinical Trials Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Offering
    • 6.1.1. Software/Platforms
    • 6.1.2. Services
  • 6.2. Market Analysis, Insights and Forecast - By Technology
    • 6.2.1. Machine Learning
    • 6.2.2. Natural Language Processing
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Patient Recruitment & Retention
    • 6.3.2. Trial Design & Protocol Optimization
    • 6.3.3. Data Collection & Management
    • 6.3.4. Predictive Analytics & Outcome Modelling
    • 6.3.5. Others
  • 6.4. Market Analysis, Insights and Forecast - By Specialty
    • 6.4.1. Oncology
    • 6.4.2. Neurology
    • 6.4.3. Cardiovascular
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By End User
    • 6.5.1. Pharmaceutical Companies
    • 6.5.2. Contract Research Organizations (CROs)
    • 6.5.3. Others
  • 6.6. Market Analysis, Insights and Forecast - By Country
    • 6.6.1. U.S.
    • 6.6.2. Canada

7. Europe AI in Clinical Trials Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Offering
    • 7.1.1. Software/Platforms
    • 7.1.2. Services
  • 7.2. Market Analysis, Insights and Forecast - By Technology
    • 7.2.1. Machine Learning
    • 7.2.2. Natural Language Processing
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Patient Recruitment & Retention
    • 7.3.2. Trial Design & Protocol Optimization
    • 7.3.3. Data Collection & Management
    • 7.3.4. Predictive Analytics & Outcome Modelling
    • 7.3.5. Others
  • 7.4. Market Analysis, Insights and Forecast - By Specialty
    • 7.4.1. Oncology
    • 7.4.2. Neurology
    • 7.4.3. Cardiovascular
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By End User
    • 7.5.1. Pharmaceutical Companies
    • 7.5.2. Contract Research Organizations (CROs)
    • 7.5.3. Others
  • 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.6.1. U.K.
    • 7.6.2. Germany
    • 7.6.3. France
    • 7.6.4. Spain
    • 7.6.5. Italy
    • 7.6.6. Scandinavia
    • 7.6.7. Rest of Europe

8. Asia Pacific AI in Clinical Trials Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Offering
    • 8.1.1. Software/Platforms
    • 8.1.2. Services
  • 8.2. Market Analysis, Insights and Forecast - By Technology
    • 8.2.1. Machine Learning
    • 8.2.2. Natural Language Processing
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Patient Recruitment & Retention
    • 8.3.2. Trial Design & Protocol Optimization
    • 8.3.3. Data Collection & Management
    • 8.3.4. Predictive Analytics & Outcome Modelling
    • 8.3.5. Others
  • 8.4. Market Analysis, Insights and Forecast - By Specialty
    • 8.4.1. Oncology
    • 8.4.2. Neurology
    • 8.4.3. Cardiovascular
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By End User
    • 8.5.1. Pharmaceutical Companies
    • 8.5.2. Contract Research Organizations (CROs)
    • 8.5.3. Others
  • 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. Australia
    • 8.6.5. Southeast Asia
    • 8.6.6. Rest of Asia Pacific

9. Latin America AI in Clinical Trials Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Offering
    • 9.1.1. Software/Platforms
    • 9.1.2. Services
  • 9.2. Market Analysis, Insights and Forecast - By Technology
    • 9.2.1. Machine Learning
    • 9.2.2. Natural Language Processing
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Patient Recruitment & Retention
    • 9.3.2. Trial Design & Protocol Optimization
    • 9.3.3. Data Collection & Management
    • 9.3.4. Predictive Analytics & Outcome Modelling
    • 9.3.5. Others
  • 9.4. Market Analysis, Insights and Forecast - By Specialty
    • 9.4.1. Oncology
    • 9.4.2. Neurology
    • 9.4.3. Cardiovascular
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By End User
    • 9.5.1. Pharmaceutical Companies
    • 9.5.2. Contract Research Organizations (CROs)
    • 9.5.3. Others
  • 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.6.1. Brazil
    • 9.6.2. Mexico
    • 9.6.3. Rest of Latin America

10. Middle East & Africa AI in Clinical Trials Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Offering
    • 10.1.1. Software/Platforms
    • 10.1.2. Services
  • 10.2. Market Analysis, Insights and Forecast - By Technology
    • 10.2.1. Machine Learning
    • 10.2.2. Natural Language Processing
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By Application
    • 10.3.1. Patient Recruitment & Retention
    • 10.3.2. Trial Design & Protocol Optimization
    • 10.3.3. Data Collection & Management
    • 10.3.4. Predictive Analytics & Outcome Modelling
    • 10.3.5. Others
  • 10.4. Market Analysis, Insights and Forecast - By Specialty
    • 10.4.1. Oncology
    • 10.4.2. Neurology
    • 10.4.3. Cardiovascular
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By End User
    • 10.5.1. Pharmaceutical Companies
    • 10.5.2. Contract Research Organizations (CROs)
    • 10.5.3. Others
  • 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.6.1. GCC
    • 10.6.2. South Africa
    • 10.6.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Products & Services, SWOT analysis, Recent developments, strategies, financials (based on availability))
    • 11.2.1. IQVIA Inc.
    • 11.2.2. Dassault Systemes
    • 11.2.3. AiCure
    • 11.2.4. Insilico Medicine
    • 11.2.5. TEMPUS
    • 11.2.6. Median Technologies
    • 11.2.7. Saama
    • 11.2.8. IBM
    • 11.2.9. NVIDIA Corporation
    • 11.2.10. Phesi

List of Tables

  • Table 1: Global AI in Clinical Trials Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 2: Global AI in Clinical Trials Market Revenue (USD billion) Forecast, By Technology, 2021-2034
  • Table 3: Global AI in Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 4: Global AI in Clinical Trials Market Revenue (USD billion) Forecast, By Specialty, 2021-2034
  • Table 5: Global AI in Clinical Trials Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 6: Global AI in Clinical Trials Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 7: North America AI in Clinical Trials Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 8: North America AI in Clinical Trials Market Revenue (USD billion) Forecast, By Technology, 2021-2034
  • Table 9: North America AI in Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 10: North America AI in Clinical Trials Market Revenue (USD billion) Forecast, By Specialty, 2021-2034
  • Table 11: North America AI in Clinical Trials Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 12: North America AI in Clinical Trials Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 13: Europe AI in Clinical Trials Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 14: Europe AI in Clinical Trials Market Revenue (USD billion) Forecast, By Technology, 2021-2034
  • Table 15: Europe AI in Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 16: Europe AI in Clinical Trials Market Revenue (USD billion) Forecast, By Specialty, 2021-2034
  • Table 17: Europe AI in Clinical Trials Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 18: Europe AI in Clinical Trials Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 19: Asia Pacific AI in Clinical Trials Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 20: Asia Pacific AI in Clinical Trials Market Revenue (USD billion) Forecast, By Technology, 2021-2034
  • Table 21: Asia Pacific AI in Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 22: Asia Pacific AI in Clinical Trials Market Revenue (USD billion) Forecast, By Specialty, 2021-2034
  • Table 23: Asia Pacific AI in Clinical Trials Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 24: Asia Pacific AI in Clinical Trials Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 25: Latin America AI in Clinical Trials Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 26: Latin America AI in Clinical Trials Market Revenue (USD billion) Forecast, By Technology, 2021-2034
  • Table 27: Latin America AI in Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 28: Latin America AI in Clinical Trials Market Revenue (USD billion) Forecast, By Specialty, 2021-2034
  • Table 29: Latin America AI in Clinical Trials Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 30: Latin America AI in Clinical Trials Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 31: Middle East & Africa AI in Clinical Trials Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 32: Middle East & Africa AI in Clinical Trials Market Revenue (USD billion) Forecast, By Technology, 2021-2034
  • Table 33: Middle East & Africa AI in Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 34: Middle East & Africa AI in Clinical Trials Market Revenue (USD billion) Forecast, By Specialty, 2021-2034
  • Table 35: Middle East & Africa AI in Clinical Trials Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 36: Middle East & Africa AI in Clinical Trials Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global AI in Clinical Trials Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global AI in Clinical Trials Market Value Share (%), By Offering, 2025 & 2034
  • Figure 3: Global AI in Clinical Trials Market Value Share (%), By Technology, 2025 & 2034
  • Figure 4: Global AI in Clinical Trials Market Value Share (%), By Application, 2025 & 2034
  • Figure 5: Global AI in Clinical Trials Market Value Share (%), By Specialty, 2025 & 2034
  • Figure 6: Global AI in Clinical Trials Market Value Share (%), By End User, 2025 & 2034
  • Figure 7: Global AI in Clinical Trials Market Value (USD billion), by Region, 2025 & 2034
  • Figure 8: North America AI in Clinical Trials Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 9: North America AI in Clinical Trials Market Value Share (%), By Offering, 2025
  • Figure 10: North America AI in Clinical Trials Market Value (USD billion), By Technology, 2025 & 2034
  • Figure 11: North America AI in Clinical Trials Market Value Share (%), By Technology, 2025
  • Figure 12: North America AI in Clinical Trials Market Value (USD billion), By Application, 2025 & 2034
  • Figure 13: North America AI in Clinical Trials Market Value Share (%), By Application, 2025
  • Figure 14: North America AI in Clinical Trials Market Value (USD billion), By Specialty, 2025 & 2034
  • Figure 15: North America AI in Clinical Trials Market Value Share (%), By Specialty, 2025
  • Figure 16: North America AI in Clinical Trials Market Value (USD billion), By End User, 2025 & 2034
  • Figure 17: North America AI in Clinical Trials Market Value Share (%), By End User, 2025
  • Figure 18: North America AI in Clinical Trials Market Value (USD billion), By Country, 2025 & 2034
  • Figure 19: North America AI in Clinical Trials Market Value Share (%), By Country, 2025
  • Figure 20: Europe AI in Clinical Trials Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 21: Europe AI in Clinical Trials Market Value Share (%), By Offering, 2025
  • Figure 22: Europe AI in Clinical Trials Market Value (USD billion), By Technology, 2025 & 2034
  • Figure 23: Europe AI in Clinical Trials Market Value Share (%), By Technology, 2025
  • Figure 24: Europe AI in Clinical Trials Market Value (USD billion), By Application, 2025 & 2034
  • Figure 25: Europe AI in Clinical Trials Market Value Share (%), By Application, 2025
  • Figure 26: Europe AI in Clinical Trials Market Value (USD billion), By Specialty, 2025 & 2034
  • Figure 27: Europe AI in Clinical Trials Market Value Share (%), By Specialty, 2025
  • Figure 28: Europe AI in Clinical Trials Market Value (USD billion), By End User, 2025 & 2034
  • Figure 29: Europe AI in Clinical Trials Market Value Share (%), By End User, 2025
  • Figure 30: Europe AI in Clinical Trials Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 31: Europe AI in Clinical Trials Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 32: Asia Pacific AI in Clinical Trials Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 33: Asia Pacific AI in Clinical Trials Market Value Share (%), By Offering, 2025
  • Figure 34: Asia Pacific AI in Clinical Trials Market Value (USD billion), By Technology, 2025 & 2034
  • Figure 35: Asia Pacific AI in Clinical Trials Market Value Share (%), By Technology, 2025
  • Figure 36: Asia Pacific AI in Clinical Trials Market Value (USD billion), By Application, 2025 & 2034
  • Figure 37: Asia Pacific AI in Clinical Trials Market Value Share (%), By Application, 2025
  • Figure 38: Asia Pacific AI in Clinical Trials Market Value (USD billion), By Specialty, 2025 & 2034
  • Figure 39: Asia Pacific AI in Clinical Trials Market Value Share (%), By Specialty, 2025
  • Figure 40: Asia Pacific AI in Clinical Trials Market Value (USD billion), By End User, 2025 & 2034
  • Figure 41: Asia Pacific AI in Clinical Trials Market Value Share (%), By End User, 2025
  • Figure 42: Asia Pacific AI in Clinical Trials Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 43: Asia Pacific AI in Clinical Trials Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 44: Latin America AI in Clinical Trials Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 45: Latin America AI in Clinical Trials Market Value Share (%), By Offering, 2025
  • Figure 46: Latin America AI in Clinical Trials Market Value (USD billion), By Technology, 2025 & 2034
  • Figure 47: Latin America AI in Clinical Trials Market Value Share (%), By Technology, 2025
  • Figure 48: Latin America AI in Clinical Trials Market Value (USD billion), By Application, 2025 & 2034
  • Figure 49: Latin America AI in Clinical Trials Market Value Share (%), By Application, 2025
  • Figure 50: Latin America AI in Clinical Trials Market Value (USD billion), By Specialty, 2025 & 2034
  • Figure 51: Latin America AI in Clinical Trials Market Value Share (%), By Specialty, 2025
  • Figure 52: Latin America AI in Clinical Trials Market Value (USD billion), By End User, 2025 & 2034
  • Figure 53: Latin America AI in Clinical Trials Market Value Share (%), By End User, 2025
  • Figure 54: Latin America AI in Clinical Trials Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 55: Latin America AI in Clinical Trials Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 56: Middle East & Africa AI in Clinical Trials Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 57: Middle East & Africa AI in Clinical Trials Market Value Share (%), By Offering, 2025
  • Figure 58: Middle East & Africa AI in Clinical Trials Market Value (USD billion), By Technology, 2025 & 2034
  • Figure 59: Middle East & Africa AI in Clinical Trials Market Value Share (%), By Technology, 2025
  • Figure 60: Middle East & Africa AI in Clinical Trials Market Value (USD billion), By Application, 2025 & 2034
  • Figure 61: Middle East & Africa AI in Clinical Trials Market Value Share (%), By Application, 2025
  • Figure 62: Middle East & Africa AI in Clinical Trials Market Value (USD billion), By Specialty, 2025 & 2034
  • Figure 63: Middle East & Africa AI in Clinical Trials Market Value Share (%), By Specialty, 2025
  • Figure 64: Middle East & Africa AI in Clinical Trials Market Value (USD billion), By End User, 2025 & 2034
  • Figure 65: Middle East & Africa AI in Clinical Trials Market Value Share (%), By End User, 2025
  • Figure 66: Middle East & Africa AI in Clinical Trials Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 67: Middle East & Africa AI in Clinical Trials Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 68: Global AI in Clinical Trials Market Share (%), By Company, 2025